New lead reported in tumor angiogenesis
Scientists supported by the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, have added a key new piece to the puzzle of how tumor cells induce new blood vessels to form and fuel their abnormal growth, a well-known process called angiogenesis. As published in this month's issue of the journal Cancer Cell, the scientists found that i...Growth factor-promoting angiogenesis expressed in tumor cells and normal neurons
Scientists have discovered that a stem cell factor overexpressed both in brain tumor cells and in neurons following brain injury promotes tumor survival by inducing angiogenesis. The research study, published in the April issue of Cancer Cell, examines the interaction between tumor cells and surrounding tissues and may have substantial significance for design of more effective therapeutics for on...Schepens scientists are first to discover angiogenesis switch inside blood vessel cells
Scientists at Schepens Eye Research Institute, an affiliate of Harvard Medical School, are the first to discover a switch inside blood vessel cells that controls angiogenesis (new blood vessel growth). The switch, they learned, is turned on and off by the balance between two enzymes (known as PI3K and PLCg) that compete for the use of the same lipid membrane to fulfill opposite missions, growth a...New angiogenesis finding may help fight cancer growth
A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs the formation of blood vessels, or angiogenesis. The finding may help halt tumor growth in cancer patients, says Emery Bresnick, the senior author on the study, a professor of pharmacology and member of the UW-Madison Paul P. Carbone...Intrinsic eye protein halts angiogenesis
Dr. Jayakrishna Ambati, of the University of Kentucky, and Dr. Balamurali Ambati, of the Medical College of Georgia, have jointly published a paper in the journal Nature detailing major research discoveries in corneal avascularity and angiogenesis. In their paper published online Oct. 18, 2006, the researchers present evidence that unravels the mystery of how a healthy cornea remains clea...Angiotensin Converting Enzyme Colorimetric Assay Kit from Alpco Diagnostics
Description:...Porcine Angiotensin Converting Enzyme from BIOPUR
Description:Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...Mouse Anti-Human Angiogenin Monoclonal Antibody, Unconjugated, Clone 14017.7 from Sigma-Aldrich
Description:Immunogen: purified recombinant human angiogenin expressed in . Physical form: Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline. Titertest method: ELISA (c). WB. Titertest values: capture ELISA 1-2 μg/mL immunoblotting 1-2 μg/mL...ChemiArray Mouse Lysate Angiogenesis Antibody Array I , 25 cytokines per membrane from CHEMICON
Description:Chemicons protein array systems, known as ChemiArrayTM Mouse Cytokine Antibody Arrays, are particularly useful compared with current methodologies. Besides the ability to detect protein expression, Chemicons systems present a more accurate reflection of active cytokine levels because they only detect secreted cytokines, and no amplification step is needed. Furthermore, it is simpler, faster, envi...ProteoMass Angiotensin II MALDI-MS Standard from Sigma-Aldrich
Description:Mol wt: monoisotopic mol wt1,045.5423 Da by calculation...An Image-Based Assay of Endothelial Cell Tube Formation as a Model of Angiogenesis
Formation of new blood vessels is fundamental to the development of cancerous cell masses and has therefore been the focus of many drug screening and cell signaling research studies. Blood vessel development is a significant event in the development and growth of solid tumors, and is implicated in wound h...Angiotensin-II-receptor blockers - Treat kidney failure
Drugs used to treat high blood pressure have been found to also help slow the progress of kidney failure. Three separate drug trials reveal that the angiotensin-II-receptor blockers, which include losartan and irbesartan, can be used to treat kidney failure, one of the commonest complications in diabetes. // In the first trial, carried out by doctors in Boston, USA, 1500 patients...Magnetic resonance angiography in clinical medicine
Cardiovascular, eurovascular and other vascular diseases are the leading causes of death. Imaging of blood vessels thus important in depiction of stenotic, occlusive, aneurismal, inflammatory or vascular malformations.Conventional x-ray angiography and digital subtraction angiography (DSA) are used to depict vascular lesions with high accuracy via intravascular administration of contrast (dye) ma...Statins reduce risks for angioplasty patients
Cholesterol-lowering drugs that help prevent heart disease also appear to cut the risk of a heart attack and other complications after angioplasty.// Angioplasty, an alternative to bypass surgery, allows doctors to open clogged coronary arteries without major surgery by inserting a tiny balloon to the narrowest point and inflating the balloon. But 3 of every 5 patients who go through the procedur...Cholesterol Drug Helps After Angioplasty
According to researchers at the Erasmus University Hospital, a common cholesterol fighting drug, a statin called Lescol or fluvastatin, can reduce the risk of heart complications by up to 20 percent for about 1 million American each year. "This reduction in major heart events -- such as dying of heart disease or suffering another heart attack is quite impressive," said Dr. Patrick Serruys,// prof...Angioplasty Should be the Standard
A new study finds angioplasty should be the treatment of choice for heart attack patients, even if the hospital they initially //go to doesn't offer angioplasty services and they have to be transferred to another facility for treatment. Research has shown heart attack patients fare better when they are treated with angioplasty to open up the clogged blood vessel that caused the attack th...Angiotensin II RIA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-A22
Description:Angiotensin II (Ang II) is the most potent pressure agent known to date and is the biologically active peptide of the renin-angiotensin system (RAS). The proteolytic enzyme renin, synthesized, stored and secreted primarily by the juxtaglomerular cells of the kidneys, cleaves angiotensinogen to produce the decapeptide angiotensin I (Ang I) which is physiologically inactive. Ang I is rapidly cle...ACE - REA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-ACD Angiotensin Converting Enzyme
Description:Angiotensin Converting Enzyme (ACE), also known as Kininase II, is a dipeptidyl carboxypeptidase (EC 3.4.15.1) with a molecular weight of at least 129,000. The structure of this glycoprotein shows a single polypeptide chain, a polysaccharide residue and a zinc atom. ACE is present in many different cell types such as neuronal cells and renal proximal tubular cells, but is mostly found in endothel...Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
SAN DIEGO, June 18, 2007 /PRNewswire-FirstCall/ -- VicalIncorporated today announced that the company's licensee, AnGes MG,Inc. reported positive results following interim analysis of datafrom the first 41 subjects to complete a Phase 3 trial of anangiogenesis product candidate using Vical's DNA deliverytechnology. Based on the findings that the primary efficacyendpoint in the trial had...Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
Pre-clinical Data Suggests Angiolix Can Inhibit Breast CancerGrowth By 75% DALLAS and IRVINE, Calif., June 04, 2007 /PRNewswire-FirstCall/-- Access Pharmaceuticals, Inc. (Bulletin Board: ACCP) and SomantaPharmaceuticals, Inc. (Bulletin Board: SMPM) announced today that ascientific abstract outlining new preclinical efficacy data forSomanta's Angiolix has been selected for publication in t...